Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in India
ViewPantoprazole and Vonoprazan Performed Well in Preventing Peptic Ulcer Recurrence in Low-Dose Aspirin Users
ViewEffects of sitagliptin on hematological parameters, erythropoietin levels, and renal and liver functions in patients with type 2 diabetes
ViewEfficacy of Dapagliflozin and Telmisartan Combination Therapy in Reducing Albuminuria and Inflammatory Markers in Diabetic Nephropathy: A Prospective Observational Study
ViewEfficacy of atorvastatin in the management of atherosclerotic cardiovascular disease (ASCVD)
ViewExploring the Role of Sitagliptin in the Management of Type 2 Diabetes Mellitus for the Elderly: A Narrative Review
ViewDapagliflozin combined with metformin improves blood glucose, bone metabolism and bone mineral density in elderly patients with type 2 diabetes mellitus complicated with osteoporosis
ViewPlasma concentration of Azithromycin and correlation with clinical outcomes in patients with enteric fever
ViewEffects of vitamin D supplementation on diabetic foot ulcer healing: a meta-analysis
ViewEffectiveness and Safety of the Telmisartan and Amlodipine Fixed-dose Combination in Managing Hypertension among Indian Patients (TACT India Study): Rationale and Study Design
View